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Prevalence of Subclinical Rheumatic Heart Disease
in Eastern Nepal
A School-Based Cross-sectional Study
Nikesh R. Shrestha, MD; Prahlad Karki, MD; Rajan Mahto, MBBS; Keshar Gurung, MD; Naveen Pandey, MD;
Krishna Agrawal, MD; Martina Rothenbühler, MSc; Philip Urban, MD; Peter Jüni, MD; Thomas Pilgrim, MD
IMPORTANCE Although rheumatic heart disease has been nearly eradicated in high-income
countries, 3 in 4 children grow up in parts of the world where it is still endemic.
OBJECTIVES To determine the prevalence of clinically silent andmanifest rheumatic heart
disease as a function of age, sex, and socioeconomic status and to estimate age-specific
incidence.
DESIGN, SETTING, AND PARTICIPANTS In this school-based cross-sectional studywith cluster
sampling, 26 schools in the Sunsari district in Eastern Nepal with 5467 eligible children 5 to 15
years of age were randomly selected from 595 registered schools. After exclusion of 289
children, 5178 children were enrolled in the present study fromDecember 12, 2012, through
September 12, 2014. Data analysis was performed fromOctober 1, 2014, to April 15, 2015.
EXPOSURES Demographic and socioeconomic characteristics were acquired in a standardized
interview bymeans of a questionnaire customized to the age of the children. A focused
medical history was followed by a brief physical examination. Cardiac auscultation and
transthoracic echocardiography were performed by 2 independent physicians.
MAIN OUTCOMES ANDMEASURES Rheumatic heart disease according to theWorld Heart
Federation criteria.
RESULTS Themedian age of the 5178 children enrolled in the study was 10 years (interquartile
range, 8-13 years), and 2503 (48.3%) were female. The prevalence of borderline or definite
rheumatic heart disease was 10.2 (95% CI, 7.5-13.0) per 1000 children and increased with
advancing age from 5.5 (95% CI, 3.5-7.5) per 1000 children 5 years of age to 16.0 (95% CI,
14.9-17.0) in children 15 years of age, whereas themean incidence remained stable at 1.1 per
1000 children per year. Children with rheumatic heart disease were older than children
without rheumatic heart disease (median age [interquartile range], 11 [9-14] years vs 10 [8-13]
years; P = .03), more commonly female (34 [64.2%] vs 2469 [48.2%]; P = .02), andmore
frequently went to governmental schools (40 [75.5%] vs 2792 [54.5%]; P = .002). Silent
disease (n = 44) was 5 times more common thanmanifest disease (n = 9).
CONCLUSIONS AND RELEVANCE Rheumatic heart disease affects 1 in 100 schoolchildren in
Eastern Nepal, is primarily clinically silent, andmay bemore common among girls. The overall
prevalence and the ratio of manifest to subclinical disease increase with advancing age,
whereas the incidence remains stable at 1.1 per 1000 children per year. Early detection of
silent disease may help prevent progression to severe valvular damage.
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T hree in 4 children grow up in parts of the world whererheumatic heart disease (RHD) is endemic.1-3 Nearlyeradicated inhigh-incomecountries,RHDranksamong
the importantnoncommunicablediseases in low-andmiddle-
income countries. It is a sentinel of social inequality and a
physical manifestation of poverty and continues to be a sub-
stantial health care challenge in less privileged regions of the
world. An autoimmune response to group A β-hemolytic
streptococcal pharyngitis results in acute rheumatic fever, af-
fecting the large joints, brain, skin, andheart. Recurrent bouts
of rheumatic fever insidiously propel clinically silent valvu-
lar damage to clinically manifest heart disease, resulting in a
quarter of a million premature deaths every year.1
Early detection of clinically silent valvular disease and
timely implementationof secondaryantibioticpreventionmay
prevent progression to manifest disease and motivated the
implementation of echocardiographic screening programs in
sub-SaharanAfrica, Oceania, and Southeast Asia.4-7 Themean
prevalenceof clinically silentRHD is21per 1000children,with
large heterogeneity among reports across various endemic re-
gions.Thisprevalenceoutweighstheprevalenceofmanifestdis-
easebyafactorof7 to8.8TheWorldHealthOrganization (WHO)
global actionplan targets a relative reductionofnoncommuni-
cablediseasemortalityby25%by theyear 2025andprioritizes
RHD control programs in endemic regions through early
detection.9 An understanding of prevalence and incidence of
the condition and risk factors associatedwith susceptibility to
diseaseisneededtoguideactivesurveillanceandsecondarypre-
vention. The objectives of the study were to determine the
prevalence of clinically silent andmanifest RHD as a function
of age, sex, and socioeconomic status and to estimate the
age-specific incidence from available prevalence data.
Methods
Study Design and Setting
We performed a school-based cross-sectional study of RHD
among children in the Sunsari district in Eastern Nepal. Nepal
has a Human Development Index of 0.540 and ranks at 145
among all 187 listed countries in the HumanDevelopment Re-
port issuedby theUnitedNationsDevelopment Programme.10
TheSunsaridistrictbelongs to theOuterTeraiof theKoshizone,
is situated in the eastern developmental region of Nepal, and
spreadsoveranarea thesizeofNewYorkCity.Nepal’s third larg-
est city,Dharan, is the economic andpolitical center of thedis-
trict and is surroundedby52villageswith a total populationof
approximately 760000 inhabitants. The studywasplanned in
collaboration with the district education office. The observa-
tional survey was based on schools rather than communities
with the intentiontopilot integrationofa regular screeningpro-
gram into the educational system. Among a total of 595 regis-
tered schools, 503 (84.5%) were located in rural areas; 370
schools (73.6%) in the rural areas had a governmental admin-
istration, and 79 schools (85.9%) in urban areas were private.
The design of the study has been previously described.11
We applied random cluster sampling stratified by the loca-
tion and administration of the schools to reflect the socioeco-
nomic demographic distribution of the population in Eastern
Nepal.12We selected rural to urban schools in a ratio of 3:1 and
governmental to private schools in a ratio of 2:1.
The studywas accompanied by a public campaign report-
ing on RHD in local print media and local radio. Because of a
highrateof illiteracy,wescreenedaneducationalmovieonRHD
for theorientationof childrenandparents.After permissionof
thedistricteducationoffice,schoolprincipalsandteacherswere
approached in a first step and gave written informed consent
for participation in the study. Subsequently, all children from
a selected school were asked to participate in the observa-
tional survey and included unless the children themselves or
their parents or primary caregivers actively withdrew con-
sent.Dataweredeidentified.Thestudywasconductedaccord-
ing to theDeclarationofHelsinki andwas registeredwithClini-
calTrials.gov (identifier NCT 01550068).13 The study was
approved by the institutional review board of B.P. Koirala
Institute of Health Sciences and the Nepal Health Research
Council andwasgivenanexempt statusby the ethics commit-
tee of the University of Bern, Bern, Switzerland.
Data Collection
All selected schools were visited at least twice by a team of 2
physicians (N.R.S., R.M., K.G., N.P., or K.A.) and 1 nurse to in-
clude childrenwhowere absent at an earlier visit. Data on so-
cial background andmedical history were acquired in a stan-
dardized interview by means of a questionnaire customized
to the age of the children. Demographic characteristics and
socioeconomic variablesweredocumented alongwith a short
medical history followed by a physical examination (eTable 1
in the Supplement). Cardiac auscultation and echocardio-
graphic screening were performed by 2 independent physi-
cians (R.M., K.G., N.P., or K.A.)masked to the findings of each
other. Because of a lack of power sources in most schools,
echocardiography was performed using a battery-operated
portableultrasoundmachine (SamsungMedisonMySonoU6).
Patients with clinical and/or echocardiographic findings
suggestive of cardiac diseaseunderwent an independent con-
firmatoryexamination.All childrenwith signsofRHDwere in-
cluded in aprospective registry. Secondary antibiotic prophy-
laxiswas recommended inchildrenwithdefiniteRHD,whereas
yearly echocardiographic follow-up without antibiotic pre-
vention is performed among children with borderline dis-
ease. Study data were collected and managed using REDCap
electronic data capture tools hosted at the Clinical Trials Unit
of the University of Bern, Bern, Switzerland.14 A pilot study15
was performed to evaluate the feasibility of collecting infor-
mation on individuals, performing data collection and echo-
cardiographic screening, identifying barriers to implementa-
tion, and streamlining the process for the main study.
Definitions
We defined RHD according to the World Heart Federation
(WHF) criteria for individuals 20years or younger and catego-
rized RHD as definite or borderline. In brief, definite RHD re-
quires the combination of at least 2morphologic criteriawith
pathologic regurgitation or mitral stenosis or borderline dis-
ease of the aortic andmitral valves.BorderlineRHD is defined
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by at least 2 morphologic features or the presence of patho-
logic mitral or aortic regurgitation.16
Clinicallymanifestdiseasewas recorded in thepresenceof
any heart murmur in combination with borderline or definite
RHD.Clinically silentor subclinical diseasewasdocumented if
echocardiographic evidence of RHDaccording to theWHF cri-
teria was not accompanied by an audible heart murmur. The
socioeconomic score was calculated using the method sug-
gested by Kuppuswamy17 and adapted by Ghosh andGhosh.18
Statistical Analysis
Baselinecharacteristicsandclinical findingsarepresentedasfre-
quencies for categorical variables and medians (interquartile
ranges[IQRs]) forcontinuousvariables.Theassociationbetween
sex and age with respect to school attendance was evaluated
using theMann-Whitney test. We compared characteristics of
children with RHD and children without RHD using the χ2 or
Fisher test, with theWilcoxon rank sum test used for continu-
ousvariables.Weincludedallbaselinecharacteristics inunivari-
ableandmultivariablemultilevel logisticregressionmodels if the
univariablewasP< .02for thedifferenceacrossgroups.Wecon-
trolled for cluster effects (schools) and adjusted for the setting
of the school (governmental vsprivate andurbanvs rural). The
prevalenceofborderlineanddefiniteRHDaccording toagewas
modeledoverall andseparatelybysexusingPoissonregression.
Becauseno follow-updatawereavailable,weestimated the in-
cidence fromprevalenceaccording toageusing themethodde-
scribed by Leske and colleagues.19 Thismethodhas 3 underly-
ingassumptions.First,weassumethat themortality rateamong
thestudypopulationisconstantanddoesnotdependonage.Sec-
ond,weassumethat themortality rateamongchildrenandado-
lescentsyounger than16years is independentofRHD.Third,we
assumethat there isnodisease regressionand thatdiseasepro-
gression is constantover time.eFigure 1 in theSupplementpro-
vides further information regarding thedescribedmethod.We
used the WHO child growth standards and the corresponding
Stata statistical softwarepackage,version13.1 (StataCorp) toas-
sess height, weight, and body mass index (calculated as the
weight inkilogramsdividedbyheight inmeters squared)of the
study population according to the presence of RHD.
Results
FromDecember 12, 2012, through September 12, 2014, a total
of 5467 eligible children from 26 randomly selected schools
were invitedtoundergoactivesurveillance forRHD.Dataanaly-
sis was performed fromOctober 1, 2014, to April 15, 2015. Af-
terexclusionof289childrenbecauseofabsenceduringscreen-
ing visits (n = 280) or ineligible age (n = 9), 5178 children
(94.7%) were enrolled for echocardiographic screening
(Figure 1). A total of 4150 children (80.1%)were living in rural
areas, whereas 1028 children (19.9%) were living in an urban
environment; 16 governmental and 10 private schools con-
tributed 2832 (54.7%) and 2346 (45.3%) children, respec-
tively. Demographic and socioeconomic characteristics are
summarized inTable 1. Themedian age of the childrenwas 10
years (IQR, 8-13 years), and2503 (48.3%)were female. The sex
distribution of school attendees across age categories is illus-
trated in eFigure 2 in the Supplement. No significant interac-
tionwas foundbetween age and sexwith respect to school at-
tendance (P = .09).Most children lived in tin shacks (n = 3483
[67.3%]) or mud houses (n = 530 [10.2%]) in families with 2
adults (IQR, 2-4) and3 children (IQR, 2-3). Althoughmost chil-
dren lived in families with a television connection (n = 3625
[70.0%]) and cellular telephone (n = 4770 [92.1%]), few had
an Internet connection (n = 326 [6.3%]), a car (n = 56 [1.1%]),
or a motorbike (n = 899 [17.4%]). One in every 5 children in-
dicated that his/her parentswere illiterate, and almost half of
the parents were unemployed or unskilled workers.
Seven children had a documented history of acute rheu-
matic fever, and 12 reported symptoms suggestive of acute
rheumatic fever; none of either group was found to have
echocardiographic lesions consistent with RHD according to
the WHF criteria. Findings from clinical examination are
summarized in Table 2. Cardiac auscultation revealed a
heart murmur in 664 children (12.8%). Relative to the echo-
cardiographic findings, the sensitivity and specificity of a
cardiac murmur for diagnosis of RHD were 17.0% and
87.2%, respectively.
Theprevalenceof borderline or definiteRHDaccording to
the WHF criteria was 10.2 (95% CI, 7.5-13.0) per 1000 chil-
dren. Thirty-six childrenhaddefiniteRHD, and 17hadborder-
linedisease.Detailed echocardiographic findings are summa-
rized in eTable 2 in the Supplement. Childrenwith definite or
borderline RHD were older compared with children with no
RHD (median age [IQR], 11 [9-14] years vs 10 [8-13] years;
P = .03) and more commonly female (34 [64.2%] vs 2469
[48.2%]; P = .02). The prevalence of RHD was higher among
girls (13.8 per 1000 children; 95%CI, 9.2-18.3) comparedwith
boys (7.2 per 1000children; 95%CI, 4.0-10.3) (eFigure 3 in the
Supplement). Theoverall prevalenceofRHDcorrected forun-
derschooling of girls was 10.4 per 1000 children (95% CI, 7.7-
13.1). ChildrenwithRHDmore frequentlywent to governmen-
tal schools comparedwith childrenwithout RHD (40 [75.5%]
vs 2792 [54.5%]; P = .002) (Table 1).
The prevalence of RHD increased across age categories
from 5.5 per 1000 children 5 years of age (95% CI, 3.5-7.5) to
16.0 per 1000 children 15 years of age (95%CI, 14.9-17.0). The
corresponding estimated incidencewas 1.1 per 1000 children
per year,without evidenceof a change in incidence across age
categories (eFigure 1 in the Supplement). Clinically silent dis-
ease (n = 44)was 5 timesmore common than clinicallymani-
festdisease (n = 9).ChildrenwithsilentRHDwereyounger than
childrenwithclinicallymanifestdisease (medianage[IQR], 10.5
[9-13] years vs 14 [11-15] years; P = .05). Manifest disease was
exceptionally rare inprimary school childrenandwas increas-
ingly detected in the early teenage years (Figure 2). In a
multivariable analysis, older age (odds ratio, 1.11; 95%CI,0.99-
1.25; P = .049) and female sex (odds ratio, 1.86; 95% CI, 1.05-
3.29; P = .03) were associated with an increased risk of RHD,
whereas individual socioeconomic determinants were not
(Figure 3). Although childrenwere generally smaller than the
50th percentile on WHO growth charts, we identified no
difference in growth in children with RHD compared with
children without RHD (eFigure 4 in the Supplement).
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Discussion
Inthisschool-basedcross-sectionalstudy, theprevalenceofbor-
derlineordefiniteRHDamongschoolchildren inEasternNepal
amountedto10.2(95%CI,7.5-13.0)per1000children5to15years
ofage.Rheumaticheartdiseasewasmorecommoningirlscom-
paredwithboys.Theprevalence increasedacrossagecategories
in anearly linear fashion. Correspondingly, the estimated inci-
denceremainedapproximatelystableat1.1per1000childrenper
year.TheprevalenceofsubclinicalRHDwas5timeshighercom-
paredwithmanifestdisease,andtheratioofmanifesttosubclini-
cal disease increasedwith increasing age.
The observed prevalence of echocardiographically docu-
mentedRHDof 10.2 (95%CI,7.5-13.0)per 1000childrenamong
schoolchildren in Eastern Nepal in our study was consider-
ably lower comparedwith apooledestimate frompopulation-
based surveys in Southeast Asia, suggesting a prevalence of
28 (95% CI, 17-50) per 1000 children.4,6,8,20 Reports4,6-8,21-30
fromAfrica,Oceania, andLatinAmericadocumentedapreva-
lence of 7.9 (95% CI, 2.9-21.4), 14.0 (95% CI, 7.7-25.5), and 4.1
(95%CI, 2.4-7.1) per 1000 children, respectively. Themost re-
cent active surveillanceprogram inNepal, including9420stu-
dents 5 to 18 years of age in the Kathmandu Valley, docu-
mented a RHD prevalence of 1.2 per 1000 population as
assessed by cardiac auscultation only, comparable to the rate
of 1.7per 1000childrenwithRHDmanifestingwithaheartmur-
mur inour study.31 Several reasonsmayaccount for thehetero-
geneity across reports. Prevalence varies as a function of so-
cioeconomiccontext, samplingstrategy,anddiagnostic criteria
applied. In addition, differences in streptococcal strains and
genetic host susceptibilitymay contribute toheterogeneity.32
Multistage samplingwasused to approximately reflect the so-
cioeconomicdistributionof theentire region.Althoughweac-
counted for governmental and private schools and rural and
urban locationof these schools, samplingwasbasedon school
lists andwas not strictly community based. Screening among
school-going children may underestimate the true burden of
disease because of an association between school attendance
and socioeconomic status.8,26 Primary school attendance in
Nepal is 96% for boys and 91% for girls.33 Consistently, girls
accounted for 48.3%of children in thepresent survey, reflect-
ing the lower schooling rate for girls comparedwith boys.33 In
our study, theprevalence ofRHDwashigher amonggirls (13.8
per 1000 children; 95% CI, 9.2-18.3) comparedwith boys (7.2
per 1000 children; 95% CI, 4.0-10.3). After correction for un-
Figure 1. Flowchart According to Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) Statement
595 Sunsari district schools
5178 Enrolled for screening
and included into analysis
76 Suspicious findings referred
for confirmation
53 WHF borderline or definite
RHD
370 Rural governmental
schools 133 Rural private schools
13 Urban governmental
schools 79 Urban private schools
Rural governmental
13 Schools
94 Classes
2864 Children
Rural private
6 Schools
54 Classes
1510 Children
Urban governmental
3 Schools
17 Classes
180 Children
Urban private
4 Schools
39 Classes
913 Children
Sample population
26 Schools
204 Classes
5467 Children
289 Excluded
280 Absent during screening
9 Age restriction
5102 Normal echocardiographic findings
23 No pathologic findings confirmed
17 Borderline RHD 36 Definite RHD
Multistage sampling
The flowchart illustrates the sampling
procedure and screening procedure.
The Inaruwa and Itahari
municipalities were excluded.
RHD indicates rheumatic heart
disease; WHF, World Heart
Federation.
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Table 1. Sociodemographic Characteristicsa
Characteristic
Overall
(N = 5178)
Healthy
(n = 5125)
Borderline or
Definite RHD
(n = 53) P Value
Individual Characteristics
Age, median (IQR), y 10 (8-13) 10 (8-13) 11 (9-14) .03
Female sex 2503 (48.3) 2469 (48.2) 34 (64.2) .02
Family Characteristics
Type of house
Kachcha (mud roof) 530 (10.2) 520 (10.2) 10 (18.9)
.30
Tin (tin roof) 3483 (67.3) 3451 (67.4) 32 (60.4)
Wooden (wooden roof) 129 (2.5) 128 (2.5) 1 (1.9)
Pakka (cement roof) 129 (2.5) 128 (2.5) 1 (1.9)
No. of rooms
≤3 2659 (51.4) 2631 (51.4) 28 (52.8)
.504-6 2123 (41.0) 2100 (41.0) 23 (43.4)
≥7 394 (7.6) 392 (7.7) 2 (3.8)
No. of family members
Adults per household, median (IQR) 2 (2-4) 2 (2-4) 2 (2-3) .22
Children per household, median (IQR) 3 (2-3) 3 (2-3) 3 (2-3) .27
Overcrowding 1302 (25.2) 1285 (25.1) 17 (32.1) .26
Possessions
Car (≥1) 56 (1.1) 56 (1.1) 0 (0.0) >.99
Motorbike (≥1) 899 (17.4) 892 (17.4) 7 (13.2) .42
Television connection (≥1) 3625 (70.0) 3594 (70.1) 31 (58.5) .07
Cellular telephone (≥1) 4770 (92.1) 4719 (92.1) 51 (96.2) .44
Internet connection 326 (6.3) 323 (6.3) 3 (5.7) >.99
Property of books (≥10) 4264 (82.4) 4216 (82.3) 48 (90.6) .15
Estimated family income per month, $
<23 74 (1.4) 74 (1.4) 0 (0.0)
.33
23-69 707 (13.7) 696 (13.6) 11 (20.8)
70-115 1720 (33.3) 1699 (33.2) 21 (39.6)
116-173 1027 (19.9) 1017 (19.9) 10 (18.9)
174-230 649 (12.6) 646 (12.6) 3 (5.7)
231-461 825 (16.0) 819 (16.0) 6 (11.3)
>461 166 (3.2) 164 (3.2) 2 (3.8)
Characteristics of primary caregiver
Age of primary caregiver, median (IQR), y 37 (33-41) 37 (33-41) 37 (34-42) .46
Educational level of primary caregiver
Illiterate 1148 (22.2) 1137 (22.2) 11 (20.8)
.54
Primary school or literate 1683 (32.5) 1660 (32.4) 23 (43.4)
Middle school certificate 872 (16.8) 863 (16.8) 9 (17.0)
High school certificate 1097 (21.2) 1089 (21.2) 8 (15.1)
Intermediate or post–high school diploma 219 (4.2) 219 (4.3) 0 (0.0)
Graduate or postgraduate 120 (2.3) 118 (2.3) 2 (3.8)
Profession or honors 39 (0.8) 39 (0.8) 0 (0.0)
Occupation of primary caregiver
Unemployed 988 (19.1) 984 (19.2) 4 (7.5)
.01
Unskilled worker 1230 (23.8) 1207 (23.6) 23 (43.4)
Semiskilled worker 686 (13.2) 680 (13.3) 6 (11.3)
Skilled worker 506 (9.8) 503 (9.8) 3 (5.7)
Shop-owner, farmer 1385 (26.7) 1374 (26.8) 11 (20.8)
Semiprofessional 100 (1.9) 97 (1.9) 3 (5.7)
Professional 283 (5.5) 280 (5.5) 3 (5.7)
Socioeconomic status score, median (IQR) 10 (8-13) 10 (8-13) 9 (7-12) .14
Characteristics of the school
Urban 1028 (19.9) 1017 (19.8) 11 (20.8) .87
Governmental 2832 (54.7) 2792 (54.5) 40 (75.5) .002
Abbreviations: IQR, interquartile
range; RHD, rheumatic heart disease.
a Data are presented as number
(percentage) of children unless
otherwise indicated. Differences
across groups are estimated using
the χ2 or Fisher exact test or logistic
regression for categorical variables
andWilcoxon rank sum test for
continuous variables. Overcrowding
is defined as number of family
members divided by number of
rooms of 2.5 or more.
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derschooling of girls, the overall prevalence is estimated to be
higher thanobserved in thepresent survey (10.4per 1000chil-
dren; 95% CI, 7.7-13.1). Under the assumption that under-
schooling may be associated with lower socioeconomic sta-
tus, the true burden of disease may be even higher.
Several studies34-40 reported a higher prevalence of RHD
among females,whereasothersdidnot.4,8,41Althoughahigher
cumulative exposure to β-hemolytic streptococci may con-
tribute to a higher prevalence among young child-rearing
mothers, it is less likely to explain differences among chil-
dren.Theconsequenceofa femalepreponderanceofRHDmay
be further amplified once girls reach child bearing age be-
cause severe valvular damage, particularlymitral stenosis, in-
creases the risk of complications during birth not only for the
mother but also for the child.Aprevious study42 of 9463preg-
nant women documented a prevalence of significant RHD in
5 of 1000 women with a mean age of 25 years. Maternal and
fetal or neonatal mortality amounted to 20% among women
with a pregnancy complicated by RHD.
In contrast to previous analyses from Southeast Asia, we
used the recently propagated WHF criteria16 for diagnosis.
The WHF criteria are more specific and less sensitive com-
pared with the WHO criteria used in previous reports.6-8,43
Still, concerns have been raised that borderline RHD could
be a normal variant.43 The correlation between subclinical
valvular lesions and subsequent burden of symptomatic
RHD has to be thoroughly assessed. It remains unclear
which proportion of subclinical lesions progress to severe
valvular damage. Previous analyses6,20,28,44 in small patient
cohorts with limited duration of follow-up suggested regres-
sion of approximately one-third of functional lesions,
whereas morphologic changes were less likely to improve.
Moreover, the efficacy of early detection of subclinical dis-
ease and timely implementation of secondary antibiotic pre-
vention need to be determined in longitudinal studies. A
recent report41 from the Southeast Pacific documented that
90% of all children with RHD received antibiotic prevention,
and three-quarters had stable disease.
Consistentwithprevious reports,7,23weobserveda steady
increase of prevalencewith advancing age. Thehigher preva-
lence of RHD with older age was paralleled by a greater ratio
of clinically detectable disease with increasing age. Both ob-
servationsmay underscore the importance of cumulative ex-
posure to progression of disease. In line with previous
reports,4,6-8,21,23,24,28 clinically silentdiseasewas5 timesmore
frequent compared with clinically manifest disease. In addi-
tion, the sensitivity of a cardiacmurmur for diagnosis of RHD
was very low. The absolute risk of developing clinicallymani-
fest and eventually symptomatic disease is a function of the
pool of silent disease and disease duration. Itmay be hypoth-
esized that the pathologic mechanism of cumulative expo-
sure not only increases prevalence but also accelerates pro-
gression of disease. As a result of this propagation through
exposure, endemic regionswithaveryhighprevalenceofRHD
may also have a higher ratio of advanced disease in younger
children compared with regions with lower prevalence. As a
consequence, the optimal age for screening may be a func-
tion of prevalence; endemic regions with very high preva-
lence may benefit from screening at a younger age and addi-
tional screeningcomparedwith regionswith lowerprevalence.
Table 2. Clinical Findingsa
Finding
Overall
(N = 5178)
Normal
(n = 5125)
Borderline or
Definite RHD
(n = 53) P Value
z score, median (IQR)
Height −1 (−2 to −1) −1 (−2 to −1) −1 (−2 to 0) .65
Weightb −1 (−2 to −1) −1 (−2 to −1) −2 (−3 to −1) .29
BMI −1 (−1 to 0) −1 (−1 to 0) −1 (−2 to −0) .33
Waist circumference, median (IQR) 57 (53 to 64) 57 (53 to 64) 59 (54 to 64) .39
Cardiac murmur, No. (%) 664 (12.8) 655 (12.8) 9 (17.0) .36
History of ARF, No. (%) 7 (0.1) 7 (0.1) 0 (0.0) >.99
Joint pain 449 (8.7) 441 (8.6) 8 (15.1) .10
Signs of ARFc 12 (0.2) 12 (0.2) 0 >.99
Abbreviations: ARF, acute rheumatic fever; BMI, bodymass index (calculated as
weight in kilograms divided by height in meters squared); IQR, interquartile
range; RHD, rheumatic heart disease.
a Differences across groups are estimated using the χ2 or Fisher exact test or
logistic regression for categorical variables and theWilcoxon rank sum test for
continuous variables.
bWorld Health Organization child growth standards for weight are only
available for children up to 10 years old, which reduces the sample size for this
item to 2048 (16 children with borderline or definite RHD).
c Signs of ARF, includingmigrating arthritis, erythemamarginatum,
subcutaneous nodules, or chorea.
Figure 2. Ratio of Silent andManifest Rheumatic Heart Disease (RHD)
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Theprevalenceof silent andmanifest RHDwasestimatedusingPoisson regression.
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Thepresent studyhas several limitations. First, the num-
ber of children detected with RHDwasmodest, thus limiting
the robustness of prevalence estimates according to age. Sec-
ond, the present analysis is open to selection bias. School at-
tendance is likely to be associatedwith socioeconomic status
and health status. The school-based rather than community-
based design of our study may undermine the burden of dis-
ease in the least privilegedpopulationmost vulnerable todis-
ease. Conversely, every school was visited at least twice to
reduce the number of absentees to a minimum.Moreover, in
a recentmeta-analysis8of active surveillanceprograms,nosig-
nificant interaction between prevalence of RHD in school-
based vs community-based studies has been documented.
Third, we did not assess interrater reliability of echocardio-
graphic findings. All children with suspicious findings were,
however, examined by a second cardiologist (N.R.S.), and di-
agnosis ofRHDwasbasedonaconsensusdecision.Fourth,we
assumed a constant mortality rate for the model used for the
estimationof incidence anddidnot account formortality sec-
ondary to RHD. Mortality may, however, not be entirely neg-
ligible in populations with endemic streptococcal infections
because children with the findings may be more susceptible
to acute rheumatic fever that can be fatal. Fifth, our findings
provide no insights into the importance of subclinical valvu-
lar lesions on prognosis. Longitudinal studies are needed to
evaluate the efficacy of early detection of clinically silent dis-
ease on progression of disease and development of conges-
tive heart failure.
Conclusions
Rheumaticheartdiseaseaffects approximately 1 in 100school-
children inEasternNepal, isprimarily clinically silent, andmay
bemore commonamonggirls. Theoverall prevalence and the
ratio of manifest to subclinical disease increase with advanc-
ing age, whereas the estimated incidence remains stable
at 1.1 per 1000 children per year.
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Invited Commentary
Screening for Rheumatic Heart Disease in Eastern Nepal
Bongani M. Mayosi, DPhil, FCP(SA)
The burden of rheumatic heart disease in developing coun-
tries is persistently high. A systematic review1 of active sur-
veillance studies found that 28.0 per 1000 people are
affected with the disease in
SoutheastAsia, 14.0 per 1000
people inOceania, and7.9 per
1000 people in Africa. A pre-
vious surveillance study2 led to estimates that 50 million to
100million peoplemay be affectedwith rheumatic heart dis-
ease worldwide. Furthermore, a prospective study3 of symp-
tomatic patients indicated that there are serious gaps in the
translationof effective interventions into clinical practice, re-
sulting in suboptimal use of proven interventions, such as an-
tibiotic prophylaxis to prevent acute rheumatic fever and sur-
gical treatment for patients with heart failure. It is therefore
not surprising that rheumatic heart disease is a leading cause
of premature death and an important economic burden inde-
velopingcountrieswhereage-standardizeddeath ratesmaybe
more than twice those reported in current global estimates.4
The article by Shrestha et al5 in this issue of JAMA
Cardiology reports the prevalence and incidence of latent
rheumatic heart disease in schoolchildren in rural and urban
Related article page 89
Research Original Investigation Rheumatic Heart Disease in Eastern Nepal
96 JAMACardiology April 2016 Volume 1, Number 1 (Reprinted) jamacardiology.com
Downloaded From: http://jamanetwork.com/ by a University of Bern User  on 01/03/2017
